Annals of Palliative Medicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=911427, encodeId=beba91142edf, content=一个多月了，还在under view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Sun Dec 27 21:38:03 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214046, encodeId=f98212140464d, content=快，安全，需，可联系, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d04b8117489, createdName=ms7000000149540875, createdTime=Mon Apr 25 09:05:26 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120960, encodeId=75fe21209607f, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：姑息医学;肿瘤 经验分享：刚刚被踢出SCI期刊索引，大家要小心了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Mar 22 07:23:53 CST 2023, time=2023-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=802971, encodeId=fa428029e178, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一审10天不到，直接回大修，填一个checklist。降低重复率，效率真的高！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/15/1803653964003c06525a0b4c44104bd7.jpg, createdBy=ba342431868, createdName=123ba159m28暂无昵称, createdTime=Thu Jul 16 10:35:44 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096368, encodeId=c37f2096368e5, content=一直Under review 现在从step1刚跳到step3 什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44725437050, createdName=ms2000000766234501, createdTime=Thu Oct 27 00:32:15 CST 2022, time=2022-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103315, encodeId=fabc21033150b, content=偏重的研究方向：肿瘤 经验分享：11.25投稿，还在awaiting assignment。。。还不知道后续如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IkpibcjZM6dwuaic9HxhAS60oibibEnQNSh51UANKBptVhHht5D8qY6HSKyHGqib2XqD9695walIibHpC0e5PdicOYic9A/132, createdBy=e9b42414696, createdName=Layee, createdTime=Tue Nov 29 14:56:26 CST 2022, time=2022-11-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1231701, encodeId=f3b21231e0123, content=请问细胞试验用什么reporting checklis呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=166b1854417, createdName=ms3223109900227850, createdTime=Sun Jul 10 23:03:38 CST 2022, time=2022-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230861, encodeId=3d4212308612b, content=2022影响因子1.925, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Wed Jul 06 10:15:16 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084171, encodeId=f27f10841e117, content=有无最近刚投的，想问下meta分析现在还收吗？初审大概多久？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7c75421892, createdName=ms5000001780828736, createdTime=Sat Dec 25 16:08:09 CST 2021, time=2021-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006836, encodeId=5acb1006836da, content=请问apm接收骨科临床类型文章么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58f65569032, createdName=ms2000000640264829, createdTime=Wed Aug 11 07:48:06 CST 2021, time=2021-08-11, status=1, ipAttribution=)]

2020-12-27 lancet1111

一个多月了，还在under view

161 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=911427, encodeId=beba91142edf, content=一个多月了，还在under view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Sun Dec 27 21:38:03 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214046, encodeId=f98212140464d, content=快，安全，需，可联系, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d04b8117489, createdName=ms7000000149540875, createdTime=Mon Apr 25 09:05:26 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120960, encodeId=75fe21209607f, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：姑息医学;肿瘤 经验分享：刚刚被踢出SCI期刊索引，大家要小心了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Mar 22 07:23:53 CST 2023, time=2023-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=802971, encodeId=fa428029e178, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一审10天不到，直接回大修，填一个checklist。降低重复率，效率真的高！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/15/1803653964003c06525a0b4c44104bd7.jpg, createdBy=ba342431868, createdName=123ba159m28暂无昵称, createdTime=Thu Jul 16 10:35:44 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096368, encodeId=c37f2096368e5, content=一直Under review 现在从step1刚跳到step3 什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44725437050, createdName=ms2000000766234501, createdTime=Thu Oct 27 00:32:15 CST 2022, time=2022-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103315, encodeId=fabc21033150b, content=偏重的研究方向：肿瘤 经验分享：11.25投稿，还在awaiting assignment。。。还不知道后续如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IkpibcjZM6dwuaic9HxhAS60oibibEnQNSh51UANKBptVhHht5D8qY6HSKyHGqib2XqD9695walIibHpC0e5PdicOYic9A/132, createdBy=e9b42414696, createdName=Layee, createdTime=Tue Nov 29 14:56:26 CST 2022, time=2022-11-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1231701, encodeId=f3b21231e0123, content=请问细胞试验用什么reporting checklis呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=166b1854417, createdName=ms3223109900227850, createdTime=Sun Jul 10 23:03:38 CST 2022, time=2022-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230861, encodeId=3d4212308612b, content=2022影响因子1.925, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Wed Jul 06 10:15:16 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084171, encodeId=f27f10841e117, content=有无最近刚投的，想问下meta分析现在还收吗？初审大概多久？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7c75421892, createdName=ms5000001780828736, createdTime=Sat Dec 25 16:08:09 CST 2021, time=2021-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006836, encodeId=5acb1006836da, content=请问apm接收骨科临床类型文章么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58f65569032, createdName=ms2000000640264829, createdTime=Wed Aug 11 07:48:06 CST 2021, time=2021-08-11, status=1, ipAttribution=)]

2022-04-25 ms7000000149540875

快，安全，需，可联系

87 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=911427, encodeId=beba91142edf, content=一个多月了，还在under view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Sun Dec 27 21:38:03 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214046, encodeId=f98212140464d, content=快，安全，需，可联系, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d04b8117489, createdName=ms7000000149540875, createdTime=Mon Apr 25 09:05:26 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120960, encodeId=75fe21209607f, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：姑息医学;肿瘤 经验分享：刚刚被踢出SCI期刊索引，大家要小心了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Mar 22 07:23:53 CST 2023, time=2023-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=802971, encodeId=fa428029e178, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一审10天不到，直接回大修，填一个checklist。降低重复率，效率真的高！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/15/1803653964003c06525a0b4c44104bd7.jpg, createdBy=ba342431868, createdName=123ba159m28暂无昵称, createdTime=Thu Jul 16 10:35:44 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096368, encodeId=c37f2096368e5, content=一直Under review 现在从step1刚跳到step3 什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44725437050, createdName=ms2000000766234501, createdTime=Thu Oct 27 00:32:15 CST 2022, time=2022-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103315, encodeId=fabc21033150b, content=偏重的研究方向：肿瘤 经验分享：11.25投稿，还在awaiting assignment。。。还不知道后续如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IkpibcjZM6dwuaic9HxhAS60oibibEnQNSh51UANKBptVhHht5D8qY6HSKyHGqib2XqD9695walIibHpC0e5PdicOYic9A/132, createdBy=e9b42414696, createdName=Layee, createdTime=Tue Nov 29 14:56:26 CST 2022, time=2022-11-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1231701, encodeId=f3b21231e0123, content=请问细胞试验用什么reporting checklis呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=166b1854417, createdName=ms3223109900227850, createdTime=Sun Jul 10 23:03:38 CST 2022, time=2022-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230861, encodeId=3d4212308612b, content=2022影响因子1.925, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Wed Jul 06 10:15:16 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084171, encodeId=f27f10841e117, content=有无最近刚投的，想问下meta分析现在还收吗？初审大概多久？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7c75421892, createdName=ms5000001780828736, createdTime=Sat Dec 25 16:08:09 CST 2021, time=2021-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006836, encodeId=5acb1006836da, content=请问apm接收骨科临床类型文章么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58f65569032, createdName=ms2000000640264829, createdTime=Wed Aug 11 07:48:06 CST 2021, time=2021-08-11, status=1, ipAttribution=)]

2023-03-22 侠胆医心来自上海

审稿速度:2.0 | 投稿命中率:95.0
偏重的研究方向：姑息医学;肿瘤
经验分享：刚刚被踢出SCI期刊索引，大家要小心了

48 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=911427, encodeId=beba91142edf, content=一个多月了，还在under view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Sun Dec 27 21:38:03 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214046, encodeId=f98212140464d, content=快，安全，需，可联系, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d04b8117489, createdName=ms7000000149540875, createdTime=Mon Apr 25 09:05:26 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120960, encodeId=75fe21209607f, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：姑息医学;肿瘤 经验分享：刚刚被踢出SCI期刊索引，大家要小心了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Mar 22 07:23:53 CST 2023, time=2023-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=802971, encodeId=fa428029e178, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一审10天不到，直接回大修，填一个checklist。降低重复率，效率真的高！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/15/1803653964003c06525a0b4c44104bd7.jpg, createdBy=ba342431868, createdName=123ba159m28暂无昵称, createdTime=Thu Jul 16 10:35:44 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096368, encodeId=c37f2096368e5, content=一直Under review 现在从step1刚跳到step3 什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44725437050, createdName=ms2000000766234501, createdTime=Thu Oct 27 00:32:15 CST 2022, time=2022-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103315, encodeId=fabc21033150b, content=偏重的研究方向：肿瘤 经验分享：11.25投稿，还在awaiting assignment。。。还不知道后续如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IkpibcjZM6dwuaic9HxhAS60oibibEnQNSh51UANKBptVhHht5D8qY6HSKyHGqib2XqD9695walIibHpC0e5PdicOYic9A/132, createdBy=e9b42414696, createdName=Layee, createdTime=Tue Nov 29 14:56:26 CST 2022, time=2022-11-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1231701, encodeId=f3b21231e0123, content=请问细胞试验用什么reporting checklis呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=166b1854417, createdName=ms3223109900227850, createdTime=Sun Jul 10 23:03:38 CST 2022, time=2022-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230861, encodeId=3d4212308612b, content=2022影响因子1.925, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Wed Jul 06 10:15:16 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084171, encodeId=f27f10841e117, content=有无最近刚投的，想问下meta分析现在还收吗？初审大概多久？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7c75421892, createdName=ms5000001780828736, createdTime=Sat Dec 25 16:08:09 CST 2021, time=2021-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006836, encodeId=5acb1006836da, content=请问apm接收骨科临床类型文章么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58f65569032, createdName=ms2000000640264829, createdTime=Wed Aug 11 07:48:06 CST 2021, time=2021-08-11, status=1, ipAttribution=)]

2020-07-16 123ba159m28暂无昵称

审稿速度:1.0 | 投稿命中率:75.0
经验分享：一审10天不到，直接回大修，填一个checklist。降低重复率，效率真的高！！！

177 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=911427, encodeId=beba91142edf, content=一个多月了，还在under view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Sun Dec 27 21:38:03 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214046, encodeId=f98212140464d, content=快，安全，需，可联系, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d04b8117489, createdName=ms7000000149540875, createdTime=Mon Apr 25 09:05:26 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120960, encodeId=75fe21209607f, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：姑息医学;肿瘤 经验分享：刚刚被踢出SCI期刊索引，大家要小心了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Mar 22 07:23:53 CST 2023, time=2023-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=802971, encodeId=fa428029e178, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一审10天不到，直接回大修，填一个checklist。降低重复率，效率真的高！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/15/1803653964003c06525a0b4c44104bd7.jpg, createdBy=ba342431868, createdName=123ba159m28暂无昵称, createdTime=Thu Jul 16 10:35:44 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096368, encodeId=c37f2096368e5, content=一直Under review 现在从step1刚跳到step3 什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44725437050, createdName=ms2000000766234501, createdTime=Thu Oct 27 00:32:15 CST 2022, time=2022-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103315, encodeId=fabc21033150b, content=偏重的研究方向：肿瘤 经验分享：11.25投稿，还在awaiting assignment。。。还不知道后续如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IkpibcjZM6dwuaic9HxhAS60oibibEnQNSh51UANKBptVhHht5D8qY6HSKyHGqib2XqD9695walIibHpC0e5PdicOYic9A/132, createdBy=e9b42414696, createdName=Layee, createdTime=Tue Nov 29 14:56:26 CST 2022, time=2022-11-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1231701, encodeId=f3b21231e0123, content=请问细胞试验用什么reporting checklis呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=166b1854417, createdName=ms3223109900227850, createdTime=Sun Jul 10 23:03:38 CST 2022, time=2022-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230861, encodeId=3d4212308612b, content=2022影响因子1.925, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Wed Jul 06 10:15:16 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084171, encodeId=f27f10841e117, content=有无最近刚投的，想问下meta分析现在还收吗？初审大概多久？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7c75421892, createdName=ms5000001780828736, createdTime=Sat Dec 25 16:08:09 CST 2021, time=2021-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006836, encodeId=5acb1006836da, content=请问apm接收骨科临床类型文章么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58f65569032, createdName=ms2000000640264829, createdTime=Wed Aug 11 07:48:06 CST 2021, time=2021-08-11, status=1, ipAttribution=)]

2022-10-27 ms2000000766234501

一直Under review 现在从step1刚跳到step3 什么意思？

37 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=911427, encodeId=beba91142edf, content=一个多月了，还在under view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Sun Dec 27 21:38:03 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214046, encodeId=f98212140464d, content=快，安全，需，可联系, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d04b8117489, createdName=ms7000000149540875, createdTime=Mon Apr 25 09:05:26 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120960, encodeId=75fe21209607f, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：姑息医学;肿瘤 经验分享：刚刚被踢出SCI期刊索引，大家要小心了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Mar 22 07:23:53 CST 2023, time=2023-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=802971, encodeId=fa428029e178, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一审10天不到，直接回大修，填一个checklist。降低重复率，效率真的高！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/15/1803653964003c06525a0b4c44104bd7.jpg, createdBy=ba342431868, createdName=123ba159m28暂无昵称, createdTime=Thu Jul 16 10:35:44 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096368, encodeId=c37f2096368e5, content=一直Under review 现在从step1刚跳到step3 什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44725437050, createdName=ms2000000766234501, createdTime=Thu Oct 27 00:32:15 CST 2022, time=2022-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103315, encodeId=fabc21033150b, content=偏重的研究方向：肿瘤 经验分享：11.25投稿，还在awaiting assignment。。。还不知道后续如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IkpibcjZM6dwuaic9HxhAS60oibibEnQNSh51UANKBptVhHht5D8qY6HSKyHGqib2XqD9695walIibHpC0e5PdicOYic9A/132, createdBy=e9b42414696, createdName=Layee, createdTime=Tue Nov 29 14:56:26 CST 2022, time=2022-11-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1231701, encodeId=f3b21231e0123, content=请问细胞试验用什么reporting checklis呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=166b1854417, createdName=ms3223109900227850, createdTime=Sun Jul 10 23:03:38 CST 2022, time=2022-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230861, encodeId=3d4212308612b, content=2022影响因子1.925, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Wed Jul 06 10:15:16 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084171, encodeId=f27f10841e117, content=有无最近刚投的，想问下meta分析现在还收吗？初审大概多久？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7c75421892, createdName=ms5000001780828736, createdTime=Sat Dec 25 16:08:09 CST 2021, time=2021-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006836, encodeId=5acb1006836da, content=请问apm接收骨科临床类型文章么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58f65569032, createdName=ms2000000640264829, createdTime=Wed Aug 11 07:48:06 CST 2021, time=2021-08-11, status=1, ipAttribution=)]

2022-11-29 Layee 来自江苏省

偏重的研究方向：肿瘤
经验分享：11.25投稿，还在awaiting assignment。。。还不知道后续如何

41 0

[GetPortalCommentsPageByObjectIdResponse(id=911427, encodeId=beba91142edf, content=一个多月了，还在under view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Sun Dec 27 21:38:03 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214046, encodeId=f98212140464d, content=快，安全，需，可联系, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d04b8117489, createdName=ms7000000149540875, createdTime=Mon Apr 25 09:05:26 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120960, encodeId=75fe21209607f, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：姑息医学;肿瘤 经验分享：刚刚被踢出SCI期刊索引，大家要小心了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Mar 22 07:23:53 CST 2023, time=2023-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=802971, encodeId=fa428029e178, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一审10天不到，直接回大修，填一个checklist。降低重复率，效率真的高！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/15/1803653964003c06525a0b4c44104bd7.jpg, createdBy=ba342431868, createdName=123ba159m28暂无昵称, createdTime=Thu Jul 16 10:35:44 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096368, encodeId=c37f2096368e5, content=一直Under review 现在从step1刚跳到step3 什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44725437050, createdName=ms2000000766234501, createdTime=Thu Oct 27 00:32:15 CST 2022, time=2022-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103315, encodeId=fabc21033150b, content=偏重的研究方向：肿瘤 经验分享：11.25投稿，还在awaiting assignment。。。还不知道后续如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IkpibcjZM6dwuaic9HxhAS60oibibEnQNSh51UANKBptVhHht5D8qY6HSKyHGqib2XqD9695walIibHpC0e5PdicOYic9A/132, createdBy=e9b42414696, createdName=Layee, createdTime=Tue Nov 29 14:56:26 CST 2022, time=2022-11-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1231701, encodeId=f3b21231e0123, content=请问细胞试验用什么reporting checklis呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=166b1854417, createdName=ms3223109900227850, createdTime=Sun Jul 10 23:03:38 CST 2022, time=2022-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230861, encodeId=3d4212308612b, content=2022影响因子1.925, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Wed Jul 06 10:15:16 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084171, encodeId=f27f10841e117, content=有无最近刚投的，想问下meta分析现在还收吗？初审大概多久？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7c75421892, createdName=ms5000001780828736, createdTime=Sat Dec 25 16:08:09 CST 2021, time=2021-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006836, encodeId=5acb1006836da, content=请问apm接收骨科临床类型文章么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58f65569032, createdName=ms2000000640264829, createdTime=Wed Aug 11 07:48:06 CST 2021, time=2021-08-11, status=1, ipAttribution=)]

2022-07-10 ms3223109900227850

请问细胞试验用什么reporting checklis呢

61 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=911427, encodeId=beba91142edf, content=一个多月了，还在under view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Sun Dec 27 21:38:03 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214046, encodeId=f98212140464d, content=快，安全，需，可联系, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d04b8117489, createdName=ms7000000149540875, createdTime=Mon Apr 25 09:05:26 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120960, encodeId=75fe21209607f, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：姑息医学;肿瘤 经验分享：刚刚被踢出SCI期刊索引，大家要小心了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Mar 22 07:23:53 CST 2023, time=2023-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=802971, encodeId=fa428029e178, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一审10天不到，直接回大修，填一个checklist。降低重复率，效率真的高！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/15/1803653964003c06525a0b4c44104bd7.jpg, createdBy=ba342431868, createdName=123ba159m28暂无昵称, createdTime=Thu Jul 16 10:35:44 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096368, encodeId=c37f2096368e5, content=一直Under review 现在从step1刚跳到step3 什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44725437050, createdName=ms2000000766234501, createdTime=Thu Oct 27 00:32:15 CST 2022, time=2022-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103315, encodeId=fabc21033150b, content=偏重的研究方向：肿瘤 经验分享：11.25投稿，还在awaiting assignment。。。还不知道后续如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IkpibcjZM6dwuaic9HxhAS60oibibEnQNSh51UANKBptVhHht5D8qY6HSKyHGqib2XqD9695walIibHpC0e5PdicOYic9A/132, createdBy=e9b42414696, createdName=Layee, createdTime=Tue Nov 29 14:56:26 CST 2022, time=2022-11-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1231701, encodeId=f3b21231e0123, content=请问细胞试验用什么reporting checklis呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=166b1854417, createdName=ms3223109900227850, createdTime=Sun Jul 10 23:03:38 CST 2022, time=2022-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230861, encodeId=3d4212308612b, content=2022影响因子1.925, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Wed Jul 06 10:15:16 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084171, encodeId=f27f10841e117, content=有无最近刚投的，想问下meta分析现在还收吗？初审大概多久？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7c75421892, createdName=ms5000001780828736, createdTime=Sat Dec 25 16:08:09 CST 2021, time=2021-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006836, encodeId=5acb1006836da, content=请问apm接收骨科临床类型文章么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58f65569032, createdName=ms2000000640264829, createdTime=Wed Aug 11 07:48:06 CST 2021, time=2021-08-11, status=1, ipAttribution=)]

2022-07-06 ms7000002110969436

2022影响因子1.925

60 0

[GetPortalCommentsPageByObjectIdResponse(id=911427, encodeId=beba91142edf, content=一个多月了，还在under view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Sun Dec 27 21:38:03 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214046, encodeId=f98212140464d, content=快，安全，需，可联系, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d04b8117489, createdName=ms7000000149540875, createdTime=Mon Apr 25 09:05:26 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120960, encodeId=75fe21209607f, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：姑息医学;肿瘤 经验分享：刚刚被踢出SCI期刊索引，大家要小心了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Mar 22 07:23:53 CST 2023, time=2023-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=802971, encodeId=fa428029e178, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一审10天不到，直接回大修，填一个checklist。降低重复率，效率真的高！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/15/1803653964003c06525a0b4c44104bd7.jpg, createdBy=ba342431868, createdName=123ba159m28暂无昵称, createdTime=Thu Jul 16 10:35:44 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096368, encodeId=c37f2096368e5, content=一直Under review 现在从step1刚跳到step3 什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44725437050, createdName=ms2000000766234501, createdTime=Thu Oct 27 00:32:15 CST 2022, time=2022-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103315, encodeId=fabc21033150b, content=偏重的研究方向：肿瘤 经验分享：11.25投稿，还在awaiting assignment。。。还不知道后续如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IkpibcjZM6dwuaic9HxhAS60oibibEnQNSh51UANKBptVhHht5D8qY6HSKyHGqib2XqD9695walIibHpC0e5PdicOYic9A/132, createdBy=e9b42414696, createdName=Layee, createdTime=Tue Nov 29 14:56:26 CST 2022, time=2022-11-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1231701, encodeId=f3b21231e0123, content=请问细胞试验用什么reporting checklis呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=166b1854417, createdName=ms3223109900227850, createdTime=Sun Jul 10 23:03:38 CST 2022, time=2022-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230861, encodeId=3d4212308612b, content=2022影响因子1.925, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Wed Jul 06 10:15:16 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084171, encodeId=f27f10841e117, content=有无最近刚投的，想问下meta分析现在还收吗？初审大概多久？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7c75421892, createdName=ms5000001780828736, createdTime=Sat Dec 25 16:08:09 CST 2021, time=2021-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006836, encodeId=5acb1006836da, content=请问apm接收骨科临床类型文章么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58f65569032, createdName=ms2000000640264829, createdTime=Wed Aug 11 07:48:06 CST 2021, time=2021-08-11, status=1, ipAttribution=)]

2021-12-25 ms5000001780828736

有无最近刚投的，想问下meta分析现在还收吗？初审大概多久？

91 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=911427, encodeId=beba91142edf, content=一个多月了，还在under view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJicDFy5DiblgAoeyDr3pjRmqR5icAXwP53uT14xXbaKbeSicW8ulMkcX5EBc9rYmCHduwTZicicibibpkxng/132, createdBy=a49d1986596, createdName=lancet1111, createdTime=Sun Dec 27 21:38:03 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214046, encodeId=f98212140464d, content=快，安全，需，可联系, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d04b8117489, createdName=ms7000000149540875, createdTime=Mon Apr 25 09:05:26 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120960, encodeId=75fe21209607f, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：姑息医学;肿瘤 经验分享：刚刚被踢出SCI期刊索引，大家要小心了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Mar 22 07:23:53 CST 2023, time=2023-03-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=802971, encodeId=fa428029e178, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一审10天不到，直接回大修，填一个checklist。降低重复率，效率真的高！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/15/1803653964003c06525a0b4c44104bd7.jpg, createdBy=ba342431868, createdName=123ba159m28暂无昵称, createdTime=Thu Jul 16 10:35:44 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096368, encodeId=c37f2096368e5, content=一直Under review 现在从step1刚跳到step3 什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44725437050, createdName=ms2000000766234501, createdTime=Thu Oct 27 00:32:15 CST 2022, time=2022-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103315, encodeId=fabc21033150b, content=偏重的研究方向：肿瘤 经验分享：11.25投稿，还在awaiting assignment。。。还不知道后续如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IkpibcjZM6dwuaic9HxhAS60oibibEnQNSh51UANKBptVhHht5D8qY6HSKyHGqib2XqD9695walIibHpC0e5PdicOYic9A/132, createdBy=e9b42414696, createdName=Layee, createdTime=Tue Nov 29 14:56:26 CST 2022, time=2022-11-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1231701, encodeId=f3b21231e0123, content=请问细胞试验用什么reporting checklis呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=166b1854417, createdName=ms3223109900227850, createdTime=Sun Jul 10 23:03:38 CST 2022, time=2022-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230861, encodeId=3d4212308612b, content=2022影响因子1.925, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Wed Jul 06 10:15:16 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084171, encodeId=f27f10841e117, content=有无最近刚投的，想问下meta分析现在还收吗？初审大概多久？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7c75421892, createdName=ms5000001780828736, createdTime=Sat Dec 25 16:08:09 CST 2021, time=2021-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006836, encodeId=5acb1006836da, content=请问apm接收骨科临床类型文章么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58f65569032, createdName=ms2000000640264829, createdTime=Wed Aug 11 07:48:06 CST 2021, time=2021-08-11, status=1, ipAttribution=)]

2021-08-11 ms2000000640264829

请问apm接收骨科临床类型文章么

102 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务